BrainomixSAM2 achieved excellent volumetric agreement with ground-truth annotations (ICC 0.98) in acute ischemic stroke FIV segmentation, comparable to DeepISLES.
Does BrainomixSAM2 provide accurate automated follow-up infarct volume segmentation compared to expert raters and DeepISLES in patients with acute ischemic stroke?
A foundation model-derived AI tool, BrainomixSAM2, achieves automated infarct segmentation accuracy comparable to expert raters and existing state-of-the-art models in acute ischemic stroke.
Absolute Event Rate: 0% vs 0%
Background: Follow-up infarct volume (FIV) is a proposed surrogate endpoint for proof-of-concept clinical studies in acute ischemic stroke. Manual annotation of infarction on diffusion-weighted magnetic resonance imaging (DWI) is labor-intensive, costly, subject to high intra- and inter-observer variability. To address this, we evaluated the performance of a foundation model-derived approach to automated FIV segmentation. Methods: We developed BrainomixSAM2, an artificial intelligence tool for automated FIV segmentation on DWI-b1000. BrainomixSAM2 is based on MedSAM2, an adaptation of Meta’s foundation model “Segment Anything Model 2” (SAM2) optimized for medical images. We performed a two-stage fine-tuning to allow automated segmentation without prompting, trained on 344 patients. We compared BrainomixSAM2 performance with ground-truth expert raters and the current state-of-the-art automated approach (DeepISLES). Examples are provided (Figure 1). We performed validation on two independent stroke imaging registries: Cohort #1: 61 patients with suspected anterior circulation large-vessel occlusion (West Virginia University, US) Cohort #2: 59 patients with mixed anterior and posterior circulation stroke (University Hospital Královské Vinohrady, Czechia) Performance metrics included volumetric concordance (intraclass correlation coefficient (ICC)), and segmentation accuracy (Dice Similarity Index (DICE)). Results: In cohort #1 (51% females, median age=66IQR=25, median FIV=30.5ml37.6ml), the volumetric agreement (ICC) between ground-truth and BrainomixSAM2 was 0.98 0.96-0.99. The average DICE was 80.7% (SD=10.2%) (Figure 2). In cohort #2 (39% females, median age=6616, median FIV=3.9ml14.62ml, 24% posterior circulation strokes), BrainomixSAM2 performed similarly to DeepISLES: ICC = 0.98 0.97-0.99 vs. 0.99 0.97-0.99; DICE= 71.9% 20.5 vs. 71.5% 20.4; p=0.22 (Figure 3). Conclusions: BrainomixSAM2 demonstrates excellent volumetric agreement with ground-truth annotations across diverse stroke cohorts. Segmentation accuracy was comparable to the current benchmark, DeepISLES, supporting its feasibility and reliability for automated FIV assessment. Wider validation and further head-to-head evaluations are warranted.
Carone et al. (Thu,) reported a other. BrainomixSAM2 achieved excellent volumetric agreement with ground-truth annotations (ICC 0.98) in acute ischemic stroke FIV segmentation, comparable to DeepISLES.